Pfizer will study the effectiveness of its vaccine against COVID-19 by inoculating the whole population over the age of 12 in a town in southern Brazil, the company said on Wednesday.
The study will be conducted in Toledo, population 143,000, in the west of Parana state, together with Brazil's National Vaccination Program, local health authorities, a hospital and the federal university.
Pfizer said the purpose was to study the behaviour of COVID-19 in a "real life scenario" after the population has been vaccinated.
"The initiative is the first and only of its kind to be undertaken in a developing country in collaboration with the pharmaceutical company," it added.
Voting ends in first phase of election in India's Bihar
Britain's Prince William calls for optimism on environment at EarthShot Prize event
Afghanistan and Pakistan return to Istanbul for more peace talks
Groping of Mexico's president puts violence against women in spotlight
Typhoon Kalmaegi death toll hits 114 in Philippines; heads to Vietnam
